European equities traded in the US as American depositary receipts rose late Thursday morning with the S&P Europe Select ADR Index gaining 1.3% to 1,893.21.
From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and DBV Technologies (DBVT), which rose 4.2% and 3.5%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and health tech company Royal Philips (PHG), which were up 3.2% and 2.7%, respectively.
The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and medical device maker EDAP TMS (FOCL), which dropped 2.7% and 2.6%, respectively. They were followed by biotech firm Evaxion (EVAX) and oil and gas company Eni (E), which were down 2.4% and 1.7%, respectively.
The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and lender Lloyds Banking Group (LYG), which advanced 8.8% and 2.8%, respectively. They were followed by lender Barclays (BCS) and insurance company Prudential (PUK), which increased 2.6% and 2.5%, respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which fell 3.5% and 3%, respectively. They were followed by oil and gas company Shell (SHEL), which was off 0.4%.